G Gardani

2.2k total citations · 1 hit paper
67 papers, 1.7k citations indexed

About

G Gardani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, G Gardani has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in G Gardani's work include Cancer Treatment and Pharmacology (13 papers), Head and Neck Cancer Studies (11 papers) and Cancer Diagnosis and Treatment (6 papers). G Gardani is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Head and Neck Cancer Studies (11 papers) and Cancer Diagnosis and Treatment (6 papers). G Gardani collaborates with scholars based in Italy, Belgium and France. G Gardani's co-authors include Paolo Lissoni, C Chenal, M. Bolla, T. Nguyen, S Schraub, M. De Pauw, R. Le Fur, Simona Alfonsi, Jean-Claude Horiot and M. van Glabbeke and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

G Gardani

66 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1992 496 citations Jean-Claude Horiot, R. Le Fur et al. Radiotherapy and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Gardani Italy	20	660	561	499	495	286	67	1.7k
Jean-Michel Vannetzel France	14	715 1.1×	146 0.3×	383 0.8×	237 0.5×	60 0.2×	28	1.4k
Colin E. Champ United States	22	329 0.5×	81 0.1×	375 0.8×	201 0.4×	215 0.8×	77	1.8k
Sarah L. Kerns United States	26	394 0.6×	101 0.2×	659 1.3×	291 0.6×	646 2.3×	66	1.7k
Tetsuya Kawata Japan	19	149 0.2×	67 0.1×	347 0.7×	184 0.4×	243 0.8×	56	1.2k
Chul Ju Han South Korea	31	360 0.5×	23 0.0×	725 1.5×	487 1.0×	215 0.8×	75	2.5k
Gabriella Cadoni Italy	29	607 0.9×	667 1.2×	362 0.7×	317 0.6×	81 0.3×	70	2.1k
Sean Sachdev United States	18	192 0.3×	69 0.1×	237 0.5×	247 0.5×	164 0.6×	69	1.2k
Jean Simons Netherlands	18	383 0.6×	73 0.1×	820 1.6×	52 0.1×	479 1.7×	22	1.4k
Marie‐Hélène Gaugler France	26	272 0.4×	29 0.1×	396 0.8×	166 0.3×	629 2.2×	49	1.8k
Kathrin Zaugg Switzerland	22	413 0.6×	39 0.1×	325 0.7×	107 0.2×	200 0.7×	43	1.6k

Countries citing papers authored by G Gardani

Since Specialization

Citations

This map shows the geographic impact of G Gardani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Gardani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Gardani more than expected).

Fields of papers citing papers by G Gardani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Gardani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Gardani. The network helps show where G Gardani may publish in the future.

Co-authorship network of co-authors of G Gardani

This figure shows the co-authorship network connecting the top 25 collaborators of G Gardani. A scholar is included among the top collaborators of G Gardani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Gardani. G Gardani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iacovelli, Nicola Alessandro, et al.. (2014). Emerging prognostic factors in Nasopharyngeal carcinoma. 1 indexed citations

Guerra, Luca, Sofia Meregalli, R.M. Niespolo, et al.. (2013). Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging. 41(4). 702–710. 27 indexed citations

Ippolito, Davide, et al.. (2012). Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdominal Imaging. 37(6). 1032–1040. 49 indexed citations

Paccagnella, Adriano, Maria Grazia Ghi, L. Loreggian, et al.. (2009). Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study. Annals of Oncology. 21(7). 1515–1522. 127 indexed citations

Guerra, Luca, R.M. Niespolo, Davide Ippolito, et al.. (2009). Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer. Abdominal Imaging. 36(1). 38–45. 31 indexed citations

Lissoni, Paolo, Sofia Meregalli, Giovanni Messina, et al.. (2008). Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastases. The International Journal of Biological Markers. 23(2). 111–114. 1 indexed citations

Lissoni, Paolo, Sofia Meregalli, Giovanni Messina, et al.. (2008). Brain Irradiation-Induced Lymphocytosis Predicts Response in Cancer Patients with Brain Metastases. The International Journal of Biological Markers. 23(2). 111–114. 2 indexed citations

Cionini, L., G Gardani, P. Gabriele, et al.. (2007). Quality indicators in radiotherapy. Radiotherapy and Oncology. 82(2). 191–200. 35 indexed citations

Lissoni, Paolo, A. Bignami, L. Frontini, et al.. (2005). Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. The International Journal of Biological Markers. 20(2). 123–125. 15 indexed citations

10.

Lissoni, Paolo, Gabriele Fumagalli, Fernando Brivio, et al.. (2004). Endocrine Effects of Erythropoietin in Cancer Patients. Hematology. 9(5-6). 363–367. 2 indexed citations

11.

Cerea, Giulio, Massimo Vaghi, A Ardizzoia, et al.. (2003). Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.. PubMed. 23(2C). 1951–4. 87 indexed citations

12.

Lissoni, Paolo, Fabio Malugani, R Bucovec, et al.. (2002). Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.. PubMed. 15(2). 140–4. 88 indexed citations

13.

Lissoni, P., Massimo Vaghi, Luca Fumagalli, et al.. (2002). Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.. PubMed. 22(2B). 1061–4. 19 indexed citations

14.

Lissoni, Paolo, Massimo Vaghi, A Ardizzoia, et al.. (2001). Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancer.. PubMed. 22(1). 27–9. 13 indexed citations

15.

Palazzi, Mauro, et al.. (1998). Treatment planning for radiotherapy in northern Italy: a survey by the National AIFB-AIRO Committee on 3D-Treatment Planning. Radiotherapy and Oncology. 48(1). 89–94. 4 indexed citations

16.

Salvetti, Monica, et al.. (1998). Interventional Radiology and Radiotherapy for Inoperable Cholangiocarcinoma of the Extrahepatic Bile Ducts. Tumori Journal. 84(4). 467–471. 13 indexed citations

17.

Lozza, Laura, A. Cerrotta, G Gardani, et al.. (1997). Analysis of risk factors for mandibular bone radionecrosis after exclusive low dose-rate brachytherapy for oral cancer. Radiotherapy and Oncology. 44(2). 143–147. 27 indexed citations

18.

Horiot, Jean-Claude, R. Le Fur, T. Nguyen, et al.. (1992). Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiotherapy and Oncology. 25(4). 231–241. 496 indexed citations breakdown →

19.

Horiot, Jean-Claude, R. Le Fur, T. Nguyen, et al.. (1990). Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. PubMed. 26(7). 779–780. 48 indexed citations

20.

Gardani, G & A Lattuada. (1988). [Radiotherapy of low-stages seminoma. Results and controversies].. PubMed. 75(3). 204–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact